1-855-378-42281-855-378-4228
One of the out-patient rehab alternatives for clients in Butterfield who are struggling with opioid dependence and addiction is opioid maintenance therapy. Some clinics and doctors are authorized to administer certain meds to opioid addicted individuals, many of which are opioids themselves and are addictive. In low enough amounts however, the individual doesn't feel high but also does not experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first drug administered for this reason, but there are alternative choices currently to select from.
Methadone is an opioid and is meant to be taken at an out-patient clinic licensed to dispense the drug, which is taken on a daily basis as a pill or liquid. The cost of the drug is approximately $150 monthly. Buprenorphine is also an opioid-based med, and is a pill often taken one day on, one day off. But unlike Methadone which is only be administered in well-regulated clinics, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is approximately $300 monthly for the generic version of the medication. There is also a version of buprenorphine that contains naloxone, which is a drug that reverses the effects of opiates. An individual taking this formulation, also known as Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced approximately $450 monthly. Naltrexone is another med used in opioid maintenance therapy, but unlike the other medications aforementioned it is an opiate blocker and isn't an opiate. There is an option to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, it prevents someone from experience being high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 per month.
For All Drug and Alcohol Rehabilitation Programs In Butterfield, Click Here.
